Diastereomeric 6-desoxy-6-spiro-.alpha.-methylene-.gamma.-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted Michael acceptor ligand

The diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone (4a and 5a) and of oxymorphone (4b and 5b) were prepared from their parent ketones. Diastereomers 4a and 4b were obtained from the 3,14-diacetate derivatives of naltrexone (6a) and oxymorphone (6b) by r...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 27; no. 12; pp. 1718 - 1723
Main Authors Koolpe, Gary A, Nelson, Wendel L, Gioannini, T. L, Angel, Lloyd, Simon, Eric J
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 01.12.1984
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone (4a and 5a) and of oxymorphone (4b and 5b) were prepared from their parent ketones. Diastereomers 4a and 4b were obtained from the 3,14-diacetate derivatives of naltrexone (6a) and oxymorphone (6b) by reaction with the Reformatsky reagent prepared from methyl alpha-(bromomethyl)acrylate. Deacetylation with methanol completed the synthesis. Diastereomers 5a and 5b were obtained from oxiranes 8a and 8b, respectively. The oxiranes were allowed to react with the sodium salt of ethyl acetoacetate, followed by methenation and deprotection to complete the synthesis of 5a and 5b, respectively. Compound 5a was the most potent agent tested in competition against [3H]naltrexone in the opioid radioreceptor assay. At a concentration of 5 nM this compound produced a 50% inhibition of binding. The majority of this inhibition (30%) was irreversible, i.e., it remained even after extensive washing of the membrane preparation in the presence and absence of Na+. Naloxone protected against this irreversible effect. The data suggest a receptor nucleophile, perhaps a sulfhydryl group, is located where it can add to the alpha, beta-unsaturated carbonyl system of 5a.
AbstractList The diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone (4a and 5a) and of oxymorphone (4b and 5b) were prepared from their parent ketones. Diastereomers 4a and 4b were obtained from the 3,14-diacetate derivatives of naltrexone (6a) and oxymorphone (6b) by reaction with the Reformatsky reagent prepared from methyl alpha-(bromomethyl)acrylate. Deacetylation with methanol completed the synthesis. Diastereomers 5a and 5b were obtained from oxiranes 8a and 8b, respectively. The oxiranes were allowed to react with the sodium salt of ethyl acetoacetate, followed by methenation and deprotection to complete the synthesis of 5a and 5b, respectively. Compound 5a was the most potent agent tested in competition against [3H]naltrexone in the opioid radioreceptor assay. At a concentration of 5 nM this compound produced a 50% inhibition of binding. The majority of this inhibition (30%) was irreversible, i.e., it remained even after extensive washing of the membrane preparation in the presence and absence of Na+. Naloxone protected against this irreversible effect. The data suggest a receptor nucleophile, perhaps a sulfhydryl group, is located where it can add to the alpha, beta-unsaturated carbonyl system of 5a.
Author Koolpe, Gary A
Nelson, Wendel L
Simon, Eric J
Gioannini, T. L
Angel, Lloyd
Author_xml – sequence: 1
  givenname: Gary A
  surname: Koolpe
  fullname: Koolpe, Gary A
– sequence: 2
  givenname: Wendel L
  surname: Nelson
  fullname: Nelson, Wendel L
– sequence: 3
  givenname: T. L
  surname: Gioannini
  fullname: Gioannini, T. L
– sequence: 4
  givenname: Lloyd
  surname: Angel
  fullname: Angel, Lloyd
– sequence: 5
  givenname: Eric J
  surname: Simon
  fullname: Simon, Eric J
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8940808$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/6209395$$D View this record in MEDLINE/PubMed
BookMark eNptkk1vEzEQhhfUqqSFE2ckHxAckIPXzn4dUaAFVASoReK2mvXOZh289mI7Ufbf4zRRhBAne2aeeTXj15fJmbEGk-R5yuYp4-nb9cCYKEpggj9OZmnGGV2UbHGWzBjjnPKciyfJpfdrFrmUi4vkIuesElU2e3T-XoEP6NAO6JQkOW3R291Ec-pH5Sydgx57mNMBQz9pNEjnKxiGmGk2YXJWgwxxHNLG9i0EtUVPbEcM6OBwt6-AaUlUHKwb-xjPyR1qlHuSKOdwi86rRsfA9KpRQVnzj0CjTKvMKgJRi9hRWdUShxLHYB0ZHY7g4KGvmQgQaU1n3fCQAa2niPoQdwvYki9K9oCagDx2a7WK8z1NzjvQHp8dz6vkx_WH--VHevv15tPy3S0FUYpAscC8ZFUJIq8g6zBeU5ZyxqpMAnLMJKuKiqeSY1dmVdlGRwTPozFZ1XAhxFXy6qA7Ovt7E8eqB-Ulag0G7cbXRVaUvFjkEXxzAKWz3jvs6tGpAdxUp6zem17_ZXqkXxxlN82A7Yk9uhzrL4918BJ058BI5U9YWS1YycqI0QOm4o_YncrgftV5IYqsvv92V998Tq-__0yX9X6b1wcepK_XduPic_v_DvgHuWLXrw
CODEN JMCMAR
CitedBy_id crossref_primary_10_1016_0168_3659_91_90029_D
crossref_primary_10_1016_j_ejmech_2014_07_077
crossref_primary_10_1002_chin_198523209
crossref_primary_10_1016_0143_4179_85_90037_X
ContentType Journal Article
Copyright 1985 INIST-CNRS
Copyright_xml – notice: 1985 INIST-CNRS
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1021/jm00378a032
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-4804
EndPage 1723
ExternalDocumentID 10_1021_jm00378a032
6209395
8940808
ark_67375_TPS_GJ1FQX1C_3
e54670707
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Comparative Study
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: DA-0017
– fundername: NIDA NIH HHS
  grantid: DA-2370
GroupedDBID -
1WB
3EH
53G
55
55A
5GY
5RE
5VS
9M8
AABXI
ABFLS
ABMVS
ABOCM
ABPTK
ACGFS
ACJ
ACS
AENEX
AFFNX
AGXLV
AJYGW
ALMA_UNASSIGNED_HOLDINGS
ANTXH
AQSVZ
BAANH
CS3
DU5
F5P
GJ
HR
JG
JG~
L7B
LG6
MVM
NHB
OHT
P2P
RNS
ROL
TN5
W1F
WH7
X
X7M
XFK
YZZ
ZE2
ZGI
---
-~X
.55
.GJ
.HR
.K2
6TJ
ABHMW
ABJNI
ACGFO
AEQTP
AHGAQ
BSCLL
GGK
IH2
VG9
XSW
YQT
08R
1KJ
3O-
4.4
6P2
7~N
AAUGY
AAYOK
ABFRP
ABQRX
ABTAH
ABUCX
ADHLV
AEESW
AFEFF
EBS
ED~
EJD
GNL
IH9
IHE
IQODW
UBC
UI2
VF5
ZY4
AAHBH
CGR
CUPRZ
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-a383t-e7e68098a369a5fe09810120095cae2e5c097921c2ef8598d032326a0359b2333
IEDL.DBID ACS
ISSN 0022-2623
IngestDate Fri Aug 16 05:27:19 EDT 2024
Fri Aug 23 02:52:56 EDT 2024
Sat Sep 28 08:33:58 EDT 2024
Sun Oct 29 17:09:59 EDT 2023
Wed Jan 17 04:50:12 EST 2024
Thu Aug 27 13:42:12 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Pentacyclic compound
Opiate receptor
Five membered ring
Lactone
Oxygen heterocycle
Biological activity
Diastereomer
Spiran
Conformation
Oxygen nitrogen heterocycle
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a383t-e7e68098a369a5fe09810120095cae2e5c097921c2ef8598d032326a0359b2333
Notes istex:F82911B20E1D598855647B36B78174A83B93716B
ark:/67375/TPS-GJ1FQX1C-3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 6209395
PQID 75782746
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_75782746
crossref_primary_10_1021_jm00378a032
pubmed_primary_6209395
pascalfrancis_primary_8940808
istex_primary_ark_67375_TPS_GJ1FQX1C_3
acs_journals_10_1021_jm00378a032
ProviderPackageCode JG~
55A
AABXI
ACS
ACJ
AGXLV
ABMVS
1WB
BAANH
AQSVZ
W1F
ANTXH
PublicationCentury 1900
PublicationDate 1984-Dec
PublicationDateYYYYMMDD 1984-12-01
PublicationDate_xml – month: 12
  year: 1984
  text: 1984-Dec
PublicationDecade 1980
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of medicinal chemistry
PublicationTitleAlternate J. Med. Chem
PublicationYear 1984
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
SSID ssj0003123
Score 1.3769201
Snippet The diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone (4a and 5a) and of oxymorphone (4b and 5b) were prepared from...
SourceID proquest
crossref
pubmed
pascalfrancis
istex
acs
SourceType Aggregation Database
Index Database
Publisher
StartPage 1718
SubjectTerms Animals
Brain - metabolism
Cell Membrane - metabolism
Chemistry
Chromatography, Thin Layer
Exact sciences and technology
Heterocyclic compounds
Heterocyclic compounds with n hetero atom and also o and/or s, se, te hetero atoms
Hydromorphone - analogs & derivatives
Indicators and Reagents
Magnetic Resonance Spectroscopy
Male
Mass Spectrometry
Molecular Conformation
Naloxone - analogs & derivatives
Naltrexone - analogs & derivatives
Naltrexone - antagonists & inhibitors
Naltrexone - chemical synthesis
Naltrexone - metabolism
Naltrexone - pharmacology
Narcotic Antagonists - chemical synthesis
Optical Rotation
Organic chemistry
Oxymorphone - analogs & derivatives
Oxymorphone - chemical synthesis
Oxymorphone - pharmacology
Preparations and properties
Rats
Rats, Inbred Strains
Receptors, Opioid - drug effects
Receptors, Opioid - metabolism
Structure-Activity Relationship
Title Diastereomeric 6-desoxy-6-spiro-.alpha.-methylene-.gamma.-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted Michael acceptor ligand
URI http://dx.doi.org/10.1021/jm00378a032
https://api.istex.fr/ark:/67375/TPS-GJ1FQX1C-3/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/6209395
https://search.proquest.com/docview/75782746
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9swDNaG5rBd9uhWLOu66VDkVGW25Id0LLJlRYENGZICuRmSLLdeEzuwnaLerx9lOwmavW5-iIIelEiC5EeETpMg0bFKHKK4VMTj0hCwszzCDI25GwZKN_kVX78FF1fe5dyf74Jo9j341P34Y2kxUrh0GNy0PQoS0dpY56Pp9sJlLmUbUHAK4rxLw9sjtuJHlw_ET8-u5L0Nh5QlrEjSlrL4u67ZyJzxczTeZO60oSa3w3Wlhvrn70CO_57OC_Ss0zrxecsmL9Fjkx2iJ6NNsbdDNJi0ENb1GZ7tMrLKMzzAkx24df3qUe9TKi22gskbVw8OSGxKGB4JiPXZ56TN3h0SW5q6BpFmyPBaLpfwRa2rugBLWlv8bxwD-V2DOl7iPMEwvKow9_aPzGIMPS7zwsbNmyGeNrV6oCVOC4s4VcAxXsBLdpOqJuJsrwOVNqk60AD6wvkqzdMYw81uVlVe4FVhWrxzoFM1lljn2TaFUy4WNbblSmBuoIvjLqsAS91RL9JrGN9rdDX-PBtdkK6UBJFgglfEhCbgjuCSBUL6iYFHC2xmFUwtDTW-dkQoqKupSbgveAzbA4qttACHijLGjtBBBjN4g7DnJ5JR7iQsEZ5QAVicIfUTFUtfU81EH8GYyqi7Csqo8fJTsLJ2G99HpxsmjFYtqMifmw0aBt22kcWtjcML_Wg2mUZfLt3x97k7ilgfnTzg4C0BFx5YBLyPPmw4OgK-si4hmZl8XUZNNYPQC_roqGX0LWlAHcGE__b_szlGT13BvTbG5x06qIq1OQFNrVLvm3P6C2W_PEg
link.rule.ids 315,786,790,2782,27107,27955,27956,57091,57141
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwEDfT-jBe-BhMFBjzw9SnujRxPpxHVChlrFNRO2lvke04I6xNqiRFC389ZydNtQoEb_nwWWfn4rvT3f0OofPYi2Uk4iERjAviMK4I-FkOocqOmOV7Qpr6iumVN7l2Lm7cmwPU39bCABMFzFSYIP4OXcB6_2OloVIYH1I4cDuuD3pOG0KjeXvuUsumW2xwG7R6U423R6y1kCweaKGO3tB7nRXJC9iYuO5o8XeT06ie8VM0bZk2GSd3g00pBvLXHp7j_67qGXrS2KD4Qy00z9GBSo_R0Wjb-u0Y9WY1oHXVx4tdfVbRxz0820FdVy8edT4mXCMtqMwEfrBHIlUAl8QjOoKfkbqWd0B0o-oKFJwig1u-WsETsSmrHPxqqdHAcQTkPw0GeYGzGAN7Za7u9RueRhhmXGW5zqJXAzw3nXtgJE5yjT-Vw0-9hJv0eyJM_tneBCIxhTswAObC2TrJkgjDOa_WZZbjda5q9HOgExXmWGZpW9DJl8sK6-YlsDawzHFTY4C5bKiXyS3w9xJdjz8tRhPSNJYgHBzykihfeWwYME69gLuxgksNc6bNTcmVrVw5DPzAtqStYuYGLILPA2Yu13CHwqaUnqDDFFbwCmHHjTm12TCmceAEwgP_07fdWETclbakQRcBT0XYHAxFaGL-Nvhcuw_fRedbWQzXNcTIn4f1jJy2Y3h-p7PyfDdczObh5wtr_O3GGoW0i04fCHJLwAIH_APWRWdbwQ5BrnSAiKcq2xSh6W3gO14XndTy3pJ69jCggfv636s5Q0eTxfQyvPxy9fUNemwFzKmzf96iwzLfqFOw4Urxzvy6vwH0iUSz
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwEDfTKgEvfAwmCoz5YerTXJI4X36cOsoYMHVqJ-0tsh1nC2uTKknRwl_P2UlTrQIh3vLhs87J2Xenu_sdQkeJn8hYJBYRIRfEDbki4Ge5hConDu3AF9LUV3y_8M-u3PNr73oHWetaGGCihJlKE8TXu3oZJy3CgP3xx0LDpYTconDo9rzAdvVWPBlNu7OX2g5d44M7oNnbirwtYq2JZPlAE_X0R73XmZG8hI-TNF0t_m52GvUzfo4uO8ZN1sndcFWJofy1hen4Pyt7gZ61tig-aYTnJdpR2R56Mlq3gNtDg0kDbF0f49mmTqs8xgM82UBe168e9U5TrhEXVG4CQNgnsSqBU-ITHcnPSVPTOyS6YXUNik6R4Q1fLOCJWFV1Af611KjgOAbynwaLvMR5goG9qlD3-g3PYgwzLvJCZ9OrIZ6aDj4wEqeFxqEqYHPP4Sa7TYXJQ9uaQKSmgAcGwFw4X6Z5GmM479Wyygu8LFSDgg50osYcyzzrCjv5fF5j3cQE1gYWOm5rDTCXLfU8vQH-XqOr8afZ6Iy0DSYIB8e8IipQfmixkFOfcS9RcKnhzrTZKblylCctFjDHlo5KQo-FMfweMHe5hj0UDqV0H-1msII3CLtewqkTWglNmMuED35o4HiJiLknHUlZHwFPZdQeEGVkYv8O-F6bH99HR2t5jJYN1Mifhw2MrHZjeHGns_MCL5pNptHnc3t8eW2PItpHBw-EuSMImQt-QthHh2vhjkCudKCIZypflZHpcRC4fh_tNzLfkfqOxSjz3v57NYfo8eR0HH37cvH1HXpqs9BtkoDeo92qWKkDMOUq8cHs3t8Kr0ct
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diastereomeric+6-desoxy-6-spiro-.alpha.-methylene-.gamma.-butyrolactone+derivatives+of+naltrexone+and+oxymorphone.+Selective+irreversible+inhibition+of+naltrexone+binding+in+an+opioid+receptor+preparation+by+a+conformationally+restricted+Michael+acceptor+ligand&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Koolpe%2C+Gary+A&rft.au=Nelson%2C+Wendel+L&rft.au=Gioannini%2C+T.+L&rft.au=Angel%2C+Lloyd&rft.date=1984-12-01&rft.pub=American+Chemical+Society&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=27&rft.issue=12&rft.spage=1718&rft.epage=1723&rft_id=info:doi/10.1021%2Fjm00378a032&rft.externalDocID=e54670707
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon